{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:18:04Z","timestamp":1777349884552,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"10-11","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.clinbiochem.2011.03.142","type":"journal-article","created":{"date-parts":[[2011,4,19]],"date-time":"2011-04-19T05:56:10Z","timestamp":1303192570000},"page":"844-848","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["PTH inhibition rate is useful in the detection of early-stage primary hyperparathyroidism"],"prefix":"10.1016","volume":"44","author":[{"given":"Lin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-jia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-hao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie-li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0005","first-page":"333","article-title":"Hyperparathyroidism","volume":"69","author":"Taniegra","year":"2004","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0010","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1056\/NEJMcp032200","article-title":"Clinical practice. Asymptomatic primary hyperparathyroidism","volume":"350","author":"Bilezikian","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0015","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4158\/EP.11.1.49","article-title":"AACE\/AAES Task Force on Primary Hyperparathyroidism. The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism","volume":"11","year":"2005","journal-title":"Endocr Pract"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0020","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1445-5994.2003.00484.x","article-title":"Diagnosis of primary hyperparathyroidism: controversies, practical issues and the need for Australian guidelines","volume":"33","author":"Glendenning","year":"2003","journal-title":"Intern Med J"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0025","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.surg.2004.06.052","article-title":"Normocalcemic hyperparathyroidism in patients with osteoporosis","volume":"136","author":"Monchik","year":"2004","journal-title":"Surgery"},{"issue":"Suppl 2","key":"10.1016\/j.clinbiochem.2011.03.142_bb0030","first-page":"S97","article-title":"Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: clinical course and considerations bearing on the need for surgical intervention","volume":"6","author":"Parfitt","year":"1991","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0035","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jcem-67-6-1294","article-title":"Lack of biochemical progression or continuation of accelerated bone loss in mild asymptomatic primary hyperparathyroidism: evidence for biphasic disease course","volume":"67","author":"Rao","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0040","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/02813430600784443","article-title":"Diagnosis of patients with raised serum calcium level in primary care, Sweden","volume":"24","author":"Dalemo","year":"2006","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0045","article-title":"Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century","volume":"17","author":"Bilezikian","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0050","first-page":"715","article-title":"Calcium infusion suggests a \u201cset-point\u201d abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism","volume":"76","author":"Khosla","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0055","first-page":"2765","article-title":"Calcium-sensing by parathyroid glands in secondary hyperparathyroidism","volume":"83","author":"Goodman","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0060","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1093\/ndt\/14.10.2398","article-title":"The PTH\u2013calcium curve and the set point of calcium in primary and secondary hyperparathyroidism","volume":"14","author":"Malberti","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0065","first-page":"408","article-title":"Regulation of parathyroid hormone release in primary and secondary hyperparathyroidism \u2014 studies in vivo and in vitro","volume":"101","author":"Rudberg","year":"1982","journal-title":"Acta Endocrinol Copenh"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0070","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1651-2227.2006.00178.x","article-title":"Understanding diagnostic tests 3: Receiver operating characteristic curves","volume":"96","author":"Akobeng","year":"2007","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0075","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1530\/EJE-07-0132","article-title":"Evaluation of a standardized short-time calcium suppression test in healthy subjects: interest for the diagnosis of primary hyperparathyroidism","volume":"157","author":"Titon","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0080","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1590\/S0100-879X2004000900013","article-title":"Response to an oral calcium load in nephrolithiasis patients with fluctuating parathyroid hormone and ionized calcium levels","volume":"37","author":"Gomes","year":"2004","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2265.1991.tb03493.x","article-title":"Stimulation and suppression of intact parathyroid hormone (PTH1-84) in normal subjects and hyperparathyroid patients","volume":"35","author":"Lips","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0090","first-page":"1026","article-title":"Oral calcium load test: diagnostic and physiologic implications in hyperparathyroidism","volume":"108","author":"McHenry","year":"1990","journal-title":"Surgery"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0095","first-page":"1103","article-title":"Role of the oral calcium-loading test with measurement of intact parathyroid hormone in the diagnosis of symptomatic subtle primary hyperparathyroidism","volume":"112","author":"Monchik","year":"1992","journal-title":"Surgery"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0100","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002239900401","article-title":"Ratio of baseline level\/maximum level of serum PTH in pseudohypoparathyroidism and primary hyperparathyroidism","volume":"62","author":"Mizunashi","year":"1998","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0105","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2265.2000.00933.x","article-title":"Calcium-sensing receptor expression and signalling in human parathyroid adenomas and primary hyperplasia","volume":"52","author":"Corbetta","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0110","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1210\/jc.2006-2802","article-title":"Normocalcemic primary hyperparathyroidism: further characterization of a new clinical phenotype","volume":"92","author":"Lowe","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0115","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s002689900111","article-title":"Parathyroid tissue in normocalcemic and hypercalcemic primary hyperparathyroidism recruited by health screening","volume":"20","author":"Lundgren","year":"1996","journal-title":"World J Surg"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0120","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s002689900126","article-title":"Parathyroid incidentalomas in normocalcemic patients during thyroid surgery","volume":"20","author":"Carnaille","year":"1996","journal-title":"World J Surg"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0125","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1210\/jc.2003-031014","article-title":"\u201cIncipient\u201d primary hyperparathyroidism: a \u201cforme fruste\u201d of an old disease","volume":"88","author":"Silverberg","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0130","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00268-002-6621-0","article-title":"Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population-based screening 8years ago","volume":"26","author":"Lundgren","year":"2002","journal-title":"World J Surg"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0135","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0039-6060(97)90357-3","article-title":"Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women","volume":"121","author":"Lundgren","year":"1997","journal-title":"Surgery"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0140","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1634\/theoncologist.12-6-644","article-title":"Primary hyperparathyroidism","volume":"12","author":"Suliburk","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0145","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0150","doi-asserted-by":"crossref","first-page":"1763S","DOI":"10.1093\/ajcn\/80.6.1763S","article-title":"Racial\/ethnic considerations in making recommendations for vitamin D for adult and elderly men and women","volume":"80","author":"Dawson-Hughes","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0155","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1017\/S0007114507844382","article-title":"Very high rates of vitamin d insufficiency in women of child-bearing age living in Beijing and Hong Kong","volume":"99","author":"Woo","year":"2008","journal-title":"Br J Nutr"},{"key":"10.1016\/j.clinbiochem.2011.03.142_bb0160","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1210\/jc.2004-1772","article-title":"Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency","volume":"90","author":"Grey","year":"2005","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991201100302X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000991201100302X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:36:04Z","timestamp":1757864164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000991201100302X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":32,"journal-issue":{"issue":"10-11","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S000991201100302X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2011.03.142","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PTH inhibition rate is useful in the detection of early-stage primary hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2011.03.142","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}